自2026年10月1日起，澳大利亚将调整COVID-19疫苗接种政策，国家COVID-19疫苗计划转入国家免疫计划，免费疫苗从全民供应转向仅限高危人群获取 1。根据新政策，75岁以上成人每6个月可获得免费疫苗，65至74岁成人每12个月可获得免费疫苗 1。此外，50至74岁的土著和托雷斯海峡岛民以及18岁以上严重免疫功能低下者仍符合免费疫苗接种资格 1。
这一政策调整引发专家关注。Adrian Esterman教授表示，患有糖尿病、其他慢性病和自身免疫病的数百万患者原本可获得免费疫苗，在新政策下将无法继续获得 1。现有接种数据也显示覆盖存在不足，75岁以上人群在过去6个月内的接种率仅为25%，65至74岁人群过去一年的接种率约为19% 1。
截至2026年，澳大利亚录得64,357例COVID-19病例，较2025年同期的146,232例下降56% 1。目前NB.1.8.1变异株在澳大利亚占据主导地位 1。
Starting October 1, 2026, Australia will transition its COVID-19 vaccination program from universal free access to a targeted approach, moving the scheme into the National Immunisation Program (NIP) 1. The new policy will limit free vaccines to adults aged 75 and over, who can receive a dose every six months, and adults aged 65 to 74, eligible for vaccination annually 1. Additionally, Aboriginal and Torres Strait Islander people aged 50 to 74 and immunocompromised individuals aged 18 and above will retain eligibility for free vaccines 1.
The policy shift has prompted concern from health experts about vulnerable populations losing access to free protection. Professor Adrian Esterman warned that millions of people with chronic conditions including diabetes, autoimmune diseases, and other chronic illnesses who previously received free vaccines will no longer be eligible 1. Current vaccination uptake among priority groups remains below target levels, with only 25 percent of people aged 75 and over vaccinated in the past six months and approximately 19 percent of those aged 65 to 74 vaccinated over the past year 1. The variant NB.1.8.1 currently dominates in Australia 1, while case numbers have declined significantly, with 64,357 cases recorded so far in 2026 compared to 146,232 cases during the corresponding period in 2025, representing a 56 percent decrease 1.
评论
还没有评论，欢迎留下第一条。